Mark Andrew, MD
Ophthalmologist
Advanced Cataract Surgery
General Ophthalmology
Age-Related Eye Disease
Intraocular Lens Implants (IOLs)
Dr. Mark Andrew brings over three decades of clinical ophthalmology experience to the ReFocus Eye Health team, specializing in general ophthalmology with a focus on non-surgical patient care. His extensive background combines comprehensive eye health management with cutting-edge research expertise, allowing him to provide patients with care informed by both clinical excellence and innovative medical insights. Dr. Andrew's approach emphasizes thoughtful diagnosis and personalized treatment plans that address each patient's unique vision needs.
Residency
Hahnemann University Hospital
Medical School
Jefferson Medical College
Professional Excellence
Dr. Andrew graduated from Jefferson Medical College in Philadelphia, where his research rotations at Wills Eye Hospital earned him an NIH grant to conduct ophthalmic research at the National Eye Institute in Bethesda, MD. After completing his ophthalmology residency at Hahnemann University Hospital, he practiced throughout California and South Jersey. His groundbreaking contributions include inventing the AquaLase® Liquefaction Device, a revolutionary cataract removal technology licensed to Alcon and now used in over 50 countries. Holding 40 patents and 6 FDA clearances, Dr. Andrew recently expanded his innovation to metabolic medicine, developing technology used in the first clinical trial removing visceral adipose tissue for type 2 diabetes treatment.
My journey through clinical practice and research has taught me that the most rewarding part of this profession is the ability to constantly learn and grow while serving my patients. Whether I'm in the exam room or developing new solutions to medical challenges, my greatest satisfaction comes from knowing that this work improves vision and quality of life for the people who trust me with their care.
Mark Andrew, MD
Welcoming Patients At:
Language:
English